Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

ASCENTAGE PHARMA GROUP

17.00
-0.3200-1.85%
Post-market: 17.000.00000.00%19:30 EDT
Volume:2K
Turnover:31.41K
Market Cap:1.59B
PE:-8.61
High:17.44
Open:17.15
Low:17.00
Close:17.32
52wk High:48.45
52wk Low:16.36
Shares:93.33M
Float Shares:71.58M
Volume Ratio:0.19
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9750
EPS(LYR):-1.9957
ROE:-236.63%
ROA:-28.04%
PB:19.16
PE(LYR):-8.52

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
ASCENTAGE PHARMA GROUP
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
767
Office Location:
Suzhou Industrial Park,68 Xinqing Road,Suzhou,Jiangsu Province,China
Website:
http://www.ascentage.com
Zip Code:
215000
Phone:
86 512 8555 7777
Fax:
- -
Introduction:
Ascentage Pharma Group is a holding company primarily engaged in the discovery, development, and commercialization of therapeutics for hematologic malignancies. Its core business focuses on developing and selling novel small-molecule therapies targeting cancer, hepatitis B, and age-related diseases. Key products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), and APG-5918, which are mainly used to treat hematologic malignancies such as chronic myeloid leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, and multiple myeloma. The company primarily operates in the domestic Chinese market.

Directors

Name
Position
YANG Da Juan
Chairman of the Board,Executive Director
WANG Shao Meng
Director,研发委员会委员
SIMON DAZHONG LU
Director,Member of the Audit Committee
Benjamin Changqing Ye
Independent Director,Member of the Remuneration and Assessment Committee,Chairman of the Audit Committee
REN Wei
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
David Sidransky
Independent Director,Chairman of the Nomination Committee,研发委员会委员
Debra Yu
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee
Marina Bozilenko
Independent Director,Member of the Audit Committee
Marc E. Lippman
Independent Director,Member of the Nomination Committee,研发委员会主席

Shareholders

Name
Position
YANG Da Juan
CEO
Veet Misra
CFO
LIANG Kai En
Corporate Secretary
DI Yi Fan
Other Senior Executives
Faiçal Miyara
Other Senior Executives
Jim Ziegler
Other Senior Executives